Device specific quality of life in subcutaneous versus transvenous implantable cardioverter defibrillator implantations: results from the ATLAS multi-centre randomized controlled trial

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Disease and symptom perceptions in cardiac arrhythmias and associated care Allied Professions in Cardiovascular Care ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by